MUSTANG BIO, INC. (MBIO) Form 8-K Material Events
MUSTANG BIO, INC. (MBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MBIO
CIK: 1680048
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerDavid Wilson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-13 | 8-K | 0001104659-26-116233 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001104659-26-091061 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001104659-26-055598 | View SEC Doc Filr Page |
| 4 | 2026-04-27 | 2026-04-24 | OWNERSHIP DOCUMENT | 0001104659-26-049430 | View SEC Doc Filr Page |
| 8-K | 2026-04-17 | 2026-04-15 | FORM 8-K | 0001104659-26-044890 | View SEC Doc Filr Page |
| 10-K | 2026-03-19 | 2025-12-31 | 10-K | 0001104659-26-032063 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-05 | — | SCHEDULE 13D/A Filing | 0001104659-26-000690 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2026-01-02 | 4 Filing | 0001429260-26-000002 | View SEC Doc Filr Page |
| 4 | 2025-12-30 | 2025-12-30 | OWNERSHIP DOCUMENT | 0001104659-25-125233 | View SEC Doc Filr Page |
| 4 | 2025-12-30 | 2025-12-30 | OWNERSHIP DOCUMENT | 0001104659-25-125232 | View SEC Doc Filr Page |
| 4 | 2025-12-30 | 2025-12-30 | OWNERSHIP DOCUMENT | 0001104659-25-125227 | View SEC Doc Filr Page |
| 8-K | 2025-12-23 | 2025-12-17 | 8-K | 0001104659-25-124189 | View SEC Doc Filr Page |
| DEF 14A | 2025-12-03 | 2025-12-22 | DEF 14A | 0001104659-25-118122 | View SEC Doc Filr Page |
| 10-Q | 2025-11-07 | 2025-09-30 | 10-Q | 0001104659-25-108468 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-10-01 | — | SCHEDULE 13D/A Filing | 0001104659-25-095631 | View SEC Doc Filr Page |
| 4 | 2025-10-01 | 2025-09-29 | 4 Filing | 0001429260-25-000004 | View SEC Doc Filr Page |
| 424B5 | 2025-09-05 | — | 424B5 | 0001104659-25-087786 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-12 | — | SCHEDULE 13G/A Filing | 0001213900-25-075080 | View SEC Doc Filr Page |
| 10-Q | 2025-08-08 | 2025-06-30 | 10-Q | 0001558370-25-010920 | View SEC Doc Filr Page |
| 8-K | 2025-07-09 | 2025-07-07 | FORM 8-K | 0001104659-25-066520 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-25-002282 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | 10-Q | 0001558370-25-007736 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-05-09 | — | SCHEDULE 13G/A Filing | 0001213900-25-041510 | View SEC Doc Filr Page |
| 4 | 2025-04-28 | 2025-04-24 | OWNERSHIP DOCUMENT | 0001104659-25-040237 | View SEC Doc Filr Page |
| EFFECT | 2025-04-11 | — | EFFECT Filing | 9999999995-25-001083 | View SEC Doc Filr Page |